Skip to main content
Log in

Cost saving antifungal prophylaxis with fluconazole

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Heng SC, et al. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy. Journal of Antimicrobial Chemotherapy : 13 Mar 2013. Available from: URL: http://dx.doi.org/10.1093/jac/dkt068

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cost saving antifungal prophylaxis with fluconazole. PharmacoEcon Outcomes News 675, 6 (2013). https://doi.org/10.1007/s40274-013-0281-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0281-1

Navigation